JILL CONWAY: Open Payments
NPI 1255308656 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 4 payments from 4 companies in 2025. Trend: 2023 $353 · 2024 $1,170 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $134 |
| GENZYME CORPORATION | 1 | $109 |
| Galderma Laboratories, L.P. | 1 | $48 |
| UCB, Inc. | 1 | $17 |
Products named: Opzelura, NEMLUVIO, Bimzelx.
Industry payments across TX — which companies pay providers there.
